Latest Products
-
Sale!

PE6 (1/8th) Dried Fruits
Original price was: $25.00.$16.25Current price is: $16.25. -
Sale!

PE6 (1oz) Dried Fruits
Original price was: $150.00.$97.50Current price is: $97.50. -
Sale!

PE6 (1LB) Dried Fruits
Original price was: $1,000.00.$650.00Current price is: $650.00. -
Sale!

Albino Makilla Gorilla (1/8th) Dried Fruits
Original price was: $30.00.$19.50Current price is: $19.50. -
Sale!

Albino Makilla Gorilla (1oz) Dried Fruits
Original price was: $175.00.$113.75Current price is: $113.75. -
Sale!

Shakti (1oz) Dried Fruits
Original price was: $150.00.$97.50Current price is: $97.50. -
Sale!

Shakti (1/8th) Dried Fruits
Original price was: $25.00.$16.25Current price is: $16.25. -
Sale!

Tidal Wave (1/8th) Dried Fruits
Original price was: $30.00.$19.50Current price is: $19.50. -
Sale!

Tidal Wave (1oz) Dried Fruits
Original price was: $200.00.$130.00Current price is: $130.00. -
Sale!

Yeti (1/8th) Dried Fruits
Original price was: $25.00.$16.25Current price is: $16.25. -
Sale!

Yeti (1oz) Dried Fruits
Original price was: $150.00.$97.50Current price is: $97.50. -
Sale!

Cosmic (1/8th) Dried Fruits
Original price was: $25.00.$16.25Current price is: $16.25.
Defining ‘Psychedelic’: What a New Research Paper Proposes — and Why It Matters for Psilocybin Trials
Key Takeaways A new paper in the Journal of Psychopharmacology proposes explicit criteria for calling a compound "psychedelic," aiming to resolve long-standing definitional ambiguity in clinical research. The authors argue that...
What the First Psilocybin Brain-Imaging Trial for Bipolar Depression Is Actually Measuring
Key Takeaways NCT06506019 is a Phase 1 trial examining psilocybin's neurobiological effects in treatment-resistant bipolar II depression, a population historically excluded from psychedelic research. The study uses fMRI imaging to measure brain connectivity changes...
What Oncology Providers Actually Think About Psychedelic-Assisted Therapy: A New Study
Key Takeaways A new qualitative study published in the American Journal of Hospice and Palliative Medicine surveyed oncology providers about their readiness to incorporate psychedelic-assisted therapy into cancer care. Clinicians expressed cautious optimism but...
Crossover Trial Compares Acute Effects of Oral Psilocybin, Oral Psilocin, and Sublingual Psilocin
Key Takeaways A randomized crossover trial published in the Journal of Psychopharmacology compared three botanical formulations: oral psilocybin, oral psilocin, and sublingual psilocin. Sublingual psilocin produced faster onset and reached peak plasma concentrations...
You must be logged in to submit a review.
